Proximity-Induced Pharmacology for Amyloid-Related Diseases

Proximity-induced pharmacology (PIP) for amyloid-related diseases is a cutting-edge approach to treating conditions such as Alzheimer’s disease and other forms of dementia. By bringing small molecules close to amyloid-related proteins, these molecules can induce a plethora of effects that can break...

Full description

Bibliographic Details
Published in:	Cells
Main Authors:	Andrea Bertran-Mostazo, Gabrielė Putriūtė, Irene Álvarez-Berbel, Maria Antònia Busquets, Carles Galdeano, Alba Espargaró, Raimon Sabate
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Subjects:	amyloid-related diseases conformational diseases neurodegenerative diseases drug discovery proximity-induced pharmacology PROTACs
Online Access:	https://www.mdpi.com/2073-4409/13/5/449

Similar Items

Analysis of Amyloid-β Pathology Spread in Mouse Models Suggests Spread Is Driven by Spatial Proximity, Not Connectivity
by: Chris Mezias, et al.
Published: (2017-12-01)

Recent advances in targeting LRRK2 for Parkinson’s disease treatment
by: Mahsa Karami, et al.
Published: (2025-07-01)

Hydroxycinnamic Acid Derivatives from Coffee Extracts Prevent Amyloid Transformation of Alpha-Synuclein
by: Maria Medvedeva, et al.
Published: (2022-09-01)

Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
by: Maksim I. Sulatsky, et al.
Published: (2025-07-01)

Amyloid, Crohn’s disease, and Alzheimer’s disease - are they linked?
by: Anna Duda-Madej, et al.
Published: (2024-05-01)

Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors
by: Villar-Piqué Anna, et al.
Published: (2012-05-01)

β-amyloid’s neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review
by: Aoife O’Connell, et al.
Published: (2024-11-01)

Single Molecule Characterization of Amyloid Oligomers
by: Jie Yang, et al.
Published: (2021-02-01)

Bleeding is increased in amyloid precursor protein knockout mouse
by: Nima Mazinani, et al.
Published: (2020-07-01)

The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases
by: Nunilo Cremades, et al.
Published: (2018-01-01)

Intraneuronal β-Amyloid Accumulation: Aging HIV-1 Human and HIV-1 Transgenic Rat Brain
by: Hailong Li, et al.
Published: (2022-06-01)

Lifting the veil on amyloid drug design
by: Kathryn E Tiller, et al.
Published: (2013-07-01)

Functional amyloid protein FXR1 is recruited into neuronal stress granules
by: Anna A. Valina, et al.
Published: (2025-12-01)

Targeting amyloid proteins for clinical diagnosis of neurodegenerative diseases
by: Shenqing Zhang, et al.
Published: (2023-07-01)

Chemical-Mediated Targeted Protein Degradation in Neurodegenerative Diseases
by: Soonsil Hyun, et al.
Published: (2021-06-01)

Protein amyloid aggregate: Structure and function
by: Qianhui Xu, et al.
Published: (2023-08-01)

Role of Pre-molten Globule Structure in Protein Amyloid Fibril Formation
by: Ali Es-haghi, et al.
Published: (2019-06-01)

Propylene Glycol induces Excessive Neurodegeneration in Combination with Amyloid Beta1-40 Toxin in Male Rat Hippocampus
by: Sajjad Salari, et al.
Published: (2024-09-01)

Exploring the Effects of Bone Marrow Mesenchymal Stem Cells on Amyloid Plaque Reduction in a Rat Model of Alzheimer's Disease
by: Annita Annita, et al.
Published: (2023-11-01)

Sideritis scardica extracts inhibit aggregation and toxicity of amyloid-β in Caenorhabditis elegans used as a model for Alzheimer’s disease
by: Felix Heiner, et al.
Published: (2018-04-01)

Conformational Sampling Deciphers the Chameleonic Properties of a VHL-Based Degrader
by: Giuseppe Ermondi, et al.
Published: (2023-01-01)

Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders
by: Tatsuya Karaki, et al.
Published: (2022-12-01)

Three to Tango: Inhibitory Effect of Quercetin and Apigenin on Acetylcholinesterase, Amyloid-β Aggregation and Acetylcholinesterase-Amyloid Interaction
by: Irene Álvarez-Berbel, et al.
Published: (2022-10-01)

The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer’s Disease
by: Ancuta-Veronica Lupaescu, et al.
Published: (2022-01-01)

A Career Long Effort to Discover a Drug to Treat Neurodegenerative Diseases. My Adventures with γ-Secretase for the Treatment of Alzheimer’s
by: Rosa María Rodríguez Sarmiento
Published: (2025-08-01)

The Peptide PROTAC Modality: A New Strategy for Drug Discovery
by: Youmin Zhu, et al.
Published: (2025-04-01)

Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
by: Lisa Sequeira, et al.
Published: (2024-05-01)

Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
by: Yu-Ling Tseng, et al.
Published: (2023-04-01)

MODELIZATION OF AMYLOID FIBRIL SELF-ASSEMBLY
by: V. Trusova, et al.
Published: (2018-04-01)

Secondary Metabolites from Plants Possessing Inhibitory Properties against Beta-Amyloid Aggregation as Revealed by Thioflavin-T Assay and Correlations with Investigations on Transgenic Mouse Models of Alzheimer’s Disease
by: Raluca Stefanescu, et al.
Published: (2020-06-01)

Editorial: Traditional medicine and phytochemicals for neurodegenerative diseases treatment: application of interdisciplinary technologies in novel therapeutic target and drug discovery
by: Chuipu Cai, et al.
Published: (2023-08-01)

Modeling Alzheimer’s disease using human cell derived brain organoids and 3D models
by: Sarah Fernandes, et al.
Published: (2024-08-01)

Molecular Role of Protein Phosphatases in Alzheimer’s and Other Neurodegenerative Diseases
by: Mubashir Hassan, et al.
Published: (2024-05-01)

Evaluating p-tau217 and p-tau231 as Biomarkers for Early Diagnosis and Differentiation of Alzheimer’s Disease: A Narrative Review
by: Dorian Julian Jarek, et al.
Published: (2024-04-01)

Seed amplification assay of nasal swab extracts for accurate and non-invasive molecular diagnosis of neurodegenerative diseases
by: Suying Duan, et al.
Published: (2023-03-01)

Relevance of biomarkers across different neurodegenerative
by: Alexander J. Ehrenberg, et al.
Published: (2020-05-01)

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
by: Xue-mei Qi, et al.
Published: (2017-08-01)

Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities
by: Linda Söderberg, et al.
Published: (2024-05-01)

Amyloids: The History of Toxicity and Functionality
by: Elmira I. Yakupova, et al.
Published: (2021-05-01)

Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
by: Mingchun Jiang, et al.
Published: (2025-02-01)